Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Harper

Showing results (211-220 of 242) with videos related to

Pageof 25
Sort By:
British Journal of Clinical Pharmacology|March 26, 2024
The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records, Christopher Wood, Victoria Speed, et al.
Annals of the Rheumatic Diseases|January 22, 2021
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohortsAngel Ys Wong, Brian MacKenna, Caroline E Morton, et al.
The Lancet. Respiratory Medicine|September 27, 2020
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platformAnna Schultze, Alex J Walker, Brian MacKenna, et al.
Plos Medicine|January 25, 2022
Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platformKrishnan Bhaskaran, Christopher T Rentsch, George Hickman, et al.
BMC Medicine|July 5, 2022
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY, Amelia Green, Helen Curtis, et al.
The Lancet. Rheumatology|March 3, 2021
Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' replyChristopher T Rentsch, Nicholas J DeVito, Brian MacKenna, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 9, 2021
OpenSAFELY NHS Service Restoration Observatory 1: primary care clinical activity in England during the first wave of COVID-19Helen J Curtis, Brian MacKenna, Richard Croker, et al.
The Lancet. Rheumatology|December 22, 2020
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platformChristopher T Rentsch, Nicholas J DeVito, Brian MacKenna, et al.
BMJ Medicine|June 12, 2023
Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY: population based, retrospective cohort study of 57 million patients using federated analyticsLouis Fisher, Lisa Em Hopcroft, Sarah Rodgers, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 19, 2021
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 FebruaryDaniel J Grint, Kevin Wing, Elizabeth Williamson, et al.
Pageof 25

Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
British Journal of Clinical Pharmacology|March 26, 2024
The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records, Christopher Wood, Victoria Speed, et al.
Annals of the Rheumatic Diseases|January 22, 2021
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohortsAngel Ys Wong, Brian MacKenna, Caroline E Morton, et al.
The Lancet. Respiratory Medicine|September 27, 2020
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platformAnna Schultze, Alex J Walker, Brian MacKenna, et al.
Plos Medicine|January 25, 2022
Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platformKrishnan Bhaskaran, Christopher T Rentsch, George Hickman, et al.
BMC Medicine|July 5, 2022
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY, Amelia Green, Helen Curtis, et al.
The Lancet. Rheumatology|March 3, 2021
Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' replyChristopher T Rentsch, Nicholas J DeVito, Brian MacKenna, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 9, 2021
OpenSAFELY NHS Service Restoration Observatory 1: primary care clinical activity in England during the first wave of COVID-19Helen J Curtis, Brian MacKenna, Richard Croker, et al.
The Lancet. Rheumatology|December 22, 2020
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platformChristopher T Rentsch, Nicholas J DeVito, Brian MacKenna, et al.
BMJ Medicine|June 12, 2023
Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY: population based, retrospective cohort study of 57 million patients using federated analyticsLouis Fisher, Lisa Em Hopcroft, Sarah Rodgers, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 19, 2021
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 FebruaryDaniel J Grint, Kevin Wing, Elizabeth Williamson, et al.
Pageof 25